These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35103928)

  • 1. A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis.
    Desai R; Batura D
    Int Urol Nephrol; 2022 Apr; 54(4):717-736. PubMed ID: 35103928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis.
    Kapoor R; Muruganandham K; Gulia AK; Singla M; Agrawal S; Mandhani A; Ansari MS; Srivastava A
    BJU Int; 2010 Apr; 105(7):986-9. PubMed ID: 19930181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis.
    Huang JJ; Tseng CC
    Arch Intern Med; 2000 Mar; 160(6):797-805. PubMed ID: 10737279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy?
    Boakes E; Batura D
    Int Urol Nephrol; 2017 Dec; 49(12):2127-2136. PubMed ID: 28933020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive techniques as a first line approach in the management of emphysematous pyelonephritis - A single centre experience.
    Gite VA; Shaw V; Agrawal M; Sankapal P; Maheshwari M
    J Postgrad Med; 2021; 67(3):146-153. PubMed ID: 34380801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emphysematous pyelonephritis.
    Ubee SS; McGlynn L; Fordham M
    BJU Int; 2011 May; 107(9):1474-8. PubMed ID: 20840327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico.
    Olvera-Posada D; Armengod-Fischer G; Vázquez-Lavista LG; Maldonado-Ávila M; Rosas-Nava E; Manzanilla-García H; Castillejos-Molina RA; Méndez-Probst CE; Sotomayor M; Feria-Bernal G; Rodríguez-Covarrubias F
    Urology; 2014 Jun; 83(6):1280-4. PubMed ID: 24726310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emphysematous pyelonephritis: an 8-year retrospective review across four acute hospitals.
    Tsu JH; Chan CK; Chu RW; Law IC; Kong CK; Liu PL; Cheung FK; Yiu MK
    Asian J Surg; 2013 Jul; 36(3):121-5. PubMed ID: 23810162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of conservative management of emphysematous pyelonephritis].
    Saadi A; Ayed H; Bouzouita A; Cherif M; Kerkeni W; Selmi S; Ben Slama R; Derouiche A; Chebil M
    Nephrol Ther; 2016 Dec; 12(7):508-515. PubMed ID: 27789323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment for emphysematous pyelonephritis: analysis of 14 cases from a single centre].
    Yu SC; Xu ZH; Zhang C; Zhu SB; Ding GQ; Li GH
    Zhonghua Wai Ke Za Zhi; 2022 Feb; 60(2):159-163. PubMed ID: 35012276
    [No Abstract]   [Full Text] [Related]  

  • 11. Emphysematous Pyelonephritis in Type 2 Diabetes - Clinical Profile and Management.
    Bhat SK; Srivastava A; Ansari NA; Rai P; Singh RP; Srivastava R; Roy AK; Fatima J
    Saudi J Kidney Dis Transpl; 2021; 32(6):1646-1654. PubMed ID: 35946277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emphysematous pyelonephritis: outcome of conservative management.
    Aswathaman K; Gopalakrishnan G; Gnanaraj L; Chacko NK; Kekre NS; Devasia A
    Urology; 2008 Jun; 71(6):1007-9. PubMed ID: 18372018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emphysematous pyelonephritis: tertiary care center experience in management and review of the literature.
    Dhabalia JV; Nelivigi GG; Kumar V; Gokhale A; Punia MS; Pujari N
    Urol Int; 2010; 85(3):304-8. PubMed ID: 20814181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing diabetic and nondiabetic emphysematous pyelonephritis and evaluating predictors of mortality.
    Kamath SU; Patil B; Shelke U; Patwardhan SK
    Saudi J Kidney Dis Transpl; 2019; 30(6):1266-1275. PubMed ID: 31929273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emphysematous pyelonephritis: outcomes of conservative management and literature review.
    Deoraj S; Zakharious F; Nasim A; Missouris C
    BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30209146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emphysematous pyelonephritis presenting as gastroenteritis.
    El-Hennawy AS; Kona H
    Am J Ther; 2007; 14(6):588-91. PubMed ID: 18090885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for failure of conservative management in patients with emphysematous pyelonephritis.
    Rahoui M; Ouanes Y; Chaker K; Bibi M; Mourad Dali K; Sellami A; Ben Rhouma S; Nouira Y
    Ann Med Surg (Lond); 2022 Jun; 78():103930. PubMed ID: 35734716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review.
    Somani BK; Nabi G; Thorpe P; Hussey J; Cook J; N'Dow J;
    J Urol; 2008 May; 179(5):1844-9. PubMed ID: 18353396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of nephrectomy and kidney-preserving procedures for the treatment of emphysematous pyelonephritis.
    Park BS; Lee SJ; Kim YW; Huh JS; Kim JI; Chang SG
    Scand J Urol Nephrol; 2006; 40(4):332-8. PubMed ID: 16916776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis.
    Khaira A; Gupta A; Rana DS; Gupta A; Bhalla A; Khullar D
    Int Urol Nephrol; 2009 Dec; 41(4):959-66. PubMed ID: 19404766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.